about
A human gut microbial gene catalogue established by metagenomic sequencingStructural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgeryHarnessing the intestinal microbiome for optimal therapeutic immunomodulationExtensive expression differences along porcine small intestine evidenced by transcriptome sequencingHost-microbe interactions in distal airways: relevance to chronic airway diseasesA metagenomic insight into our gut's microbiomeThe intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD.Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA.Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease.Why should we need the gut microbiota to respond to cancer therapies?Microbiota Is Involved in Post-resection Adaptation in Humans with Short Bowel Syndrome.Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients.Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition.Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis.Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis.Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge.Bacterial protein signals are associated with Crohn's disease.Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.Gut microbiome and anticancer immune response: really hot Sh*t!High-fat diet alters gut microbiota physiology in mice.The human gut microbiome and its dysfunctions.Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitisMetabolic interplay between gut bacteria and their host.Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance.Early-life establishment of the swine gut microbiome and impact on host phenotypes.Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth.Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.Review article: gut flora and inflammatory bowel disease.Respective Roles of Hematopoietic and Nonhematopoietic Nod2 on the Gut Microbiota and Mucosal Homeostasis.Nod2 Deficiency Leads to a Specific and Transmissible Mucosa-associated Microbial Dysbiosis Which Is Independent of the Mucosal Barrier Defect.Mining gut microbiome oligopeptides by functional metaproteome display.Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota.Does our food (environment) change our gut microbiome ('in-vironment'): a potential role for inflammatory bowel disease?Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?Hemidesmosome integrity protects the colon against colitis and colorectal cancerNutritional strategies and gut microbiota composition as risk factors for necrotizing enterocolitis in very-preterm infants.
P50
Q24618931-DEFF4B4A-EF2C-4E12-8870-774CCBF190DFQ24658549-6C867AFB-12B9-4426-B00B-398C07E216C4Q27001449-4FCBF15E-8BEE-47A4-AE4A-A7A5F8176EF7Q27322647-CB46FFAF-6903-4E00-953A-4D5E32ACF915Q28081396-F2835D79-2FF4-4FCF-9E84-BA7F6B112534Q28265135-F3956363-B65C-4AE7-8E0B-B990BAB7CDCCQ31144277-016A1B1E-E700-4D90-9477-4988DCECFBE7Q31167835-9338468A-FAE4-4CAC-8E58-8E97E4BAEA66Q33222867-060DD8EA-B8FE-49FE-9D9C-3B674E4BE4F2Q33385425-9BDF2BDC-F1EE-469F-A7FD-5FF247F7DA68Q33553530-71D271B6-3415-4D64-B1C9-38C84244F162Q33575682-0B5969BD-89CD-4AD1-BB5C-F829D5B968F4Q33593685-8B182E02-043E-4AF1-BC7C-AB7C9AAEA83AQ33777945-BCD881A2-B478-42AD-9C91-832734E62A44Q33914907-F0479220-B943-42E9-8523-C37AECB1F70EQ34001803-DE8BBD16-16D5-4090-AC35-CF858AAB1F0EQ34143650-D01D1B0C-0DBD-4F3C-A751-E67DE294B9DFQ34237245-E9689663-EEEC-4AFC-AD42-EF4F51FD3D77Q34496310-0D906811-F97C-4098-86F8-D6EA106E07F4Q34542239-15B3CF06-196F-4369-97DA-C6EDE0828FD8Q34924272-8FA97AC9-8FE0-4018-87F5-BB919C83B1C0Q34986213-9CEF645E-0511-44ED-A5AD-924066E63ECEQ35046008-646D173F-8B51-41B7-9631-C08E8CD93A91Q35073224-1DDBA16B-512A-48D7-AD3C-88BD72AC045AQ35147785-07CF37E0-5BEE-4ED8-8511-C49121F79606Q35202957-8BFAF469-B205-447C-AB77-DE32964FD633Q35569634-2E3206C5-4F54-4EA7-9438-2B263CF634D0Q35715862-30128145-F9BF-48C8-B767-9F238B1EE6B6Q35833921-56AA3B6D-BEA1-4CBA-9E01-F536BF75A463Q35862699-A5E9D383-2834-425F-934A-0A203C2A243AQ35880365-57509DEF-03A0-4B8C-8714-11732B61F387Q35952497-571443B2-758A-4341-ACB4-E57611F3D931Q36008992-2CF8D023-D49C-47A0-BEAC-0C6B52634F60Q36153085-841E5EE3-24FE-4984-90B3-0785D73F922DQ37616506-2672CFBA-C474-4B66-9926-F52AD9335858Q38072222-035FDD48-6F40-4B0D-921A-F42F6117975DQ38873283-EA9789FE-1A50-41F4-B1BD-E52CC59562E8Q39017623-BA819DDA-A168-4608-9E7C-95F501B2D93FQ39637327-2D1175BE-37D7-497F-97B6-A4384DDE6F0FQ40142108-0BDA955C-681F-44D8-91BE-1F26A3FE33ED
P50
description
researcher, ORCID id # 0000-0002-9501-6771
@en
wetenschapper
@nl
name
P Lepage
@nl
Patricia Lepage
@en
Patricia Lepage
@es
type
label
P Lepage
@nl
Patricia Lepage
@en
Patricia Lepage
@es
altLabel
P Lepage
@en
prefLabel
P Lepage
@nl
Patricia Lepage
@en
Patricia Lepage
@es
P106
P21
P31
P496
0000-0002-9501-6771